Newsletter | May 6, 2026

05.06.26 -- Regulatory Flexibility In CGT: Key Shifts & Implications With Monika Swietlicka

SPONSOR

Distributed Manufacturing for CGT: Rent, Lease, or Buy

Join Cell & Gene Live Chief Editor Erin Harris and panelists on May 12, 2026 at 11am ET for Distributed Manufacturing for CGT: Rent, Lease, or Buy. The discussion will cover how cell and gene therapy companies navigate the 2026 landscape marked by manufacturing overcapacity, a strategic question is no longer if to outsource, but how. Register for free today and plan to learn more!

FOCUS ON REGULATORY & COMPLIANCE

Regulatory Flexibility In CGT: Key Shifts And Implications With Monika Swietlicka

In this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Halloran Consulting Group's Monika Swietlicka to discuss how the FDA is increasing flexibility in CGT development without lowering evidentiary standards, emphasizing a risk-based, holistic approach.

Precision Detection Of Adapter Dimers In NGS Libraries

Identifying low-level adapter dimers is essential for sequencing success. Compare electrophoresis methods to see how different kits resolve small fragments and improve your quality control results.

Smarter Automation Strategies For Scalable Cell Therapies

By integrating automation into manufacturing workflows early, organizations can accelerate timelines, reduce resource strain, and build more reliable, scalable, and compliant production systems.

Unlock The Power Of Clinical Data Science

Adopt a unified approach to help clinical teams manage data complexity. Accelerate insight generation and improve trial oversight to enable faster, more informed decision-making across the board.

Shielded BSCs: Regulatory Requirement Or Risk-Based Engineering Solution?

Master the balance between USP <825> aseptic standards and radiation safety. Read about how integrated engineering solutions ensure regulatory compliance while protecting both patients and personnel.

Annex 1: Ensuring Sterile Pharmaceutical Manufacturing Standards

Adhering to the EMA’s Annex 1 requires strategic, risk-based compliance for facility design. These rigorous standards are fundamental to ensuring patient safety and fostering future innovation.

How Automated Microscopy Systems Improve Analytical Workflows

Automated microscopy is helping teams move faster with more consistent imaging. Learn how high-throughput systems reduce variability, support digital workflows, and strengthen decision-making.

Best Practices For Single-Use Component Interchangeability And Qualification

Explore a structured framework for qualifying single-use component changes, with risk-based strategies, supplier insights, and practical tools to support resilient and compliant biomanufacturing.

The FDA's Final BIMO "Processes And Practices" Guidance

Gain a clear roadmap for investigators, sponsors, and IRBs. This shift toward transparency replaces regulatory guesswork with predictable standards for every partner in the research ecosystem.

Navigating The Complex Regulatory World Of ATMPs/CGTs

Shifting definitions for ATMPs and CGTs impact global development. Stay informed on CMC validation requirements, European legislation, and the latest expedited regulatory pathways available today.

Lessons From FDA 483s And Warning Letters: Cleanroom Compliance

Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.

Recombinant Trypsin Frequently Asked Questions

Identify these key features of high-quality recombinant trypsin. This guide provides insightful answers to common questions about how this enzyme can benefit your specific bioprocessing goals.

Next Generation Sequencing In Viral Safety Testing

Next Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development.

High-Sensitivity Residual E. coli DNA Testing Supporting CGT Development

Advancements in high-sensitivity residual DNA testing enhance the precision of plasmid DNA purity analysis, ensuring compliance with regulatory standards critical for manufacturing processes.

Strategies For Implementing AI Systems In Regulated Pharma Environments

Uncover how AI can be safely and effectively deployed in regulated pharma environments, with practical guidance on risk, governance, and lifecycle management rooted in GAMP 5 principles.

Fast And Sensitive Mycoplasma Detection Workflow

Digital PCR enables fast, sensitive mycoplasma detection in cell-based products. See how this pharmacopeia-compliant workflow improves accuracy, reduces delays, and supports reliable decision-making.

REGULATORY & COMPLIANCE SOLUTIONS

Restore Control When It Matters Most - Ecolab Life Sciences

Standardization With A Module Type Package - Siemens

Connect With Cell & Gene: